Author Question: When selling to a buying group, a salesperson should arrive at the location before the group arrives ... (Read 241 times)

burton19126

  • Hero Member
  • *****
  • Posts: 532
When selling to a buying group, a salesperson should arrive at the location before the group arrives because:
 A) he or she can speak with the decision makers individually before the presentation begins.
  B) he or she can greet the group as a whole when the members enter the room.
  C) he or she can establish a shared space where everyone is in charge of the meeting.
  D) he or she can set up and check equipment and become familiar with the surroundings.
  E) he or she can make copies of all the visual material for all the members of the group to look through.

Question 2

Discuss why qualitative and quantitative data are needed to effectively improve customer satisfaction ratings.



orangecrush

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

D

Answer to Question 2

Quantitative satisfaction ratings provide a benchmark against which future satisfaction surveys may be compared. In addition, the quantitative ratings provides the means of comparing the firm's performance against its competition. The qualitative data provides diagnostic information and pinpoints areas for improvement. Combining the qualitative and quantitative data outperforms either approach used alone.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library